Standardization of an experimental murine model of invasive pulmonary aspergillosis.
about
In vivo efficacy of a synthetic coumarin derivative in a murine model of aspergillosisPeroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™.Aspergillus galactosaminogalactan mediates adherence to host constituents and conceals hyphal β-glucan from the immune system.Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.Development of a novel inhalational model of invasive pulmonary aspergillosis in rats and comparative evaluation of three biomarkers for its diagnosis.Cutaneous model of invasive aspergillosis.Overview of vertebrate animal models of fungal infection.Gliotoxin production in Aspergillus fumigatus contributes to host-specific differences in virulence.Development of an aerosol model of Cryptococcus reveals humidity as an important factor affecting the viability of Cryptococcus during aerosolization.Mouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-RhizopusInterlaboratory and interstudy reproducibility of a novel lateral-flow device and influence of antifungal therapy on detection of invasive pulmonary aspergillosis.Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.A new and clinically relevant murine model of solid-organ transplant aspergillosis.Animal models: an important tool in mycology.Strain-dependent variation in 18S ribosomal DNA Copy numbers in Aspergillus fumigatusHost immune defense against Aspergillus fumigatus: insight from experimental systemic (disseminated) infection.Assessment of Carvacrol for control of avian aspergillosis in intratracheally-challenged chickens in comparison to Voriconazole with a reference on economic impact.Aspergillus in chronic lung disease: Modeling what goes on in the airways.Pharmacodynamics for antifungal drug development: an approach for acceleration, risk minimization and demonstration of causality.Efficacy of the investigational echinocandin ASP9726 in a guinea pig model of invasive pulmonary aspergillosis.Detection of Aspergillus fumigatus in a rat model of invasive pulmonary aspergillosis by real-time nucleic acid sequence-based amplification.Animal Models for Studying Triazole Resistance in Aspergillus fumigatus.Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging.Dectin-1 Fc targeting of aspergillus fumigatus beta-glucans augments innate defense against invasive pulmonary aspergillosis.Inhaled voriconazole for prevention of invasive pulmonary aspergillosis.Bayesian development of a dose-response model for Aspergillus fumigatus and invasive aspergillosis.Efficacy of liposomal amphotericin B for prophylaxis of acute or reactivation models of invasive pulmonary aspergillosis.Modified release itraconazole amorphous solid dispersion to treat Aspergillus fumigatus: importance of the animal model selection.Differential strain-related tissue immune response to sublethal systemic Aspergillus fumigatus infection in mice.In-depth 2-DE reference map of Aspergillus fumigatus and its proteomic profiling on exposure to itraconazole.
P2860
Q28542402-E58939AC-3006-4E25-8DD7-42CF524C6896Q31037255-DC1B29E8-03B3-4AD4-98DB-488B073E2260Q31129835-5F7A2232-135C-413E-8747-742EA029DA58Q33689767-CE4F24EC-8257-49BD-94B5-6E9118658E81Q33793571-FC8311A8-F1F2-4D47-8C1E-351918B48122Q33826474-04707EEE-6A0E-4508-8B36-0C6C0427B17AQ34175500-1E0A5E7D-CA44-492A-A4BB-AA54FE45963FQ34736784-AB45D188-3394-4C9F-A4B2-4CA7DB9207F2Q34874531-67611182-EAFD-4B07-9177-0AA49CEB95C9Q36235415-820D95FB-2573-476E-A679-259E5A3A0A14Q36559047-7B4C7CF4-80B2-44A2-86EF-82DE7267EDA5Q36744831-E18DEA99-C5A9-4DFD-946E-03C41F3091C9Q36790931-1354C867-60D5-4BF8-8D48-D04847DE803CQ37008692-DA2CC3A1-1076-4F14-B008-48EA557F1A53Q37191546-EA57F213-6137-4D17-BB89-502CF8180743Q37990413-22C8D3F0-55B6-4FA0-BE33-5C060704ED91Q38403121-41ED2445-52DD-4C2C-95E7-D682069FE95BQ38795896-D735FF1D-CC44-4B8A-B877-19FA870F02C3Q38919690-F8891240-ADC7-461A-8147-79209A9AE37FQ39565084-7AADF6AB-7AE0-4758-B261-0C3887669BFDQ39900331-EC29CD49-D626-402A-ADCB-734F0B9688D4Q40045642-318A2A9F-D07D-453D-B5F4-2A0FB602D876Q41441699-3DA48BCF-8CBA-4EF2-8496-E4BE83D141F8Q41850770-6F6EECFB-9B58-4C79-9DF3-F7114B1E5997Q42104105-77ECF3EF-E188-4B19-8078-E10EE317E0C6Q44500220-2BCEBE98-8723-445B-9635-DE06D348C931Q45353811-2C2F3E2E-4474-411C-9352-663583B2E98FQ46688318-01B7B3F8-383D-470D-9DB6-4A38B88BE8EFQ51548827-486E0359-AEA6-4E59-8D9D-F33FD37F1A05Q53797726-2CBE7AFA-3369-4F9A-B8C7-E5ED4B5EB996
P2860
Standardization of an experimental murine model of invasive pulmonary aspergillosis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Standardization of an experimental murine model of invasive pulmonary aspergillosis.
@ast
Standardization of an experimental murine model of invasive pulmonary aspergillosis.
@en
type
label
Standardization of an experimental murine model of invasive pulmonary aspergillosis.
@ast
Standardization of an experimental murine model of invasive pulmonary aspergillosis.
@en
prefLabel
Standardization of an experimental murine model of invasive pulmonary aspergillosis.
@ast
Standardization of an experimental murine model of invasive pulmonary aspergillosis.
@en
P2093
P2860
P356
P1476
Standardization of an experimental murine model of invasive pulmonary aspergillosis.
@en
P2093
Ana C Vallor
Donald C Sheppard
John R Graybill
Laura K Najvar
Lisa Y Chiang
Rosie Bocanegra
Scott G Filler
Thomas Doedt
Thomas F Patterson
William R Kirkpatrick
P2860
P304
P356
10.1128/AAC.00787-06
P407
P577
2006-10-01T00:00:00Z